Krepler, C., Xiao, M., Sproesser, K., Brafford, P., Shannan, B., Beqiri, M., . . . Herlyn, M. (2015). Personalized pre-clinical trials in BRAF inhibitor resistant patient derived xenograft models identify second line combination therapies. Clin Cancer Res.
Style de citation ChicagoKrepler, Clemens, et al. "Personalized Pre-clinical Trials in BRAF Inhibitor Resistant Patient Derived Xenograft Models Identify Second Line Combination Therapies." Clin Cancer Res 2015.
Style de citation MLAKrepler, Clemens, et al. "Personalized Pre-clinical Trials in BRAF Inhibitor Resistant Patient Derived Xenograft Models Identify Second Line Combination Therapies." Clin Cancer Res 2015.
Attention : ces citations peuvent ne pas être correctes à 100%.